By addressing the underlying metabolic, hormonal, and lifestyle factors, patients can achieve meaningful, lasting results with the right guidance
Compounded semaglutide from licensed 503A pharmacies undergoes the same quality and sterility standards as brand-name medications, though it is not FDA-approved as a finished product
Consumers should be aware that marketing claims often exceed the available scientific evidence, and there is currently no official recognition of transdermal berberine as an effective delivery method by regulatory or clinical authorities
Your results guide PlexusDx providers to recommend the GLP-1 compound (semaglutide, tirzepatide, or the dual-compound GLP-Squared) and starting dose most likely to produce sustained weight loss with minimal side effects
A peptide that is under-dosed, contains contaminants, or has degraded due to improper synthesis or storage will not perform as expected